BOULDER, Colo., Dec. 3, 2019 /PRNewswire/ — ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated …
Read More »AstraZeneca Announces Positive Late-Stage Results for the Treatment of Hyperuricemia Associated with Gout
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced positive subanalysis data of the Phase III lesinurad studies (CLEAR1, …
Read More »